Nevin Janice Elizabeth 4

4 · CROSS COUNTRY HEALTHCARE INC · Filed Jul 21, 2026

AI-generated summary of this filing

Updated Jul 21, 2026

CCRN Director Janice Nevin Sells 48,616 Shares in Merger

What Happened

Janice Nevin (Director) disposed of 48,616 shares of Cross Country Healthcare, Inc. common stock on July 21, 2026. The shares were converted into cash at $13.25 per share, yielding $644,162. Transaction type reported as a disposition to the issuer (D) tied to the company’s merger.

Key Details

Transaction date and price: July 21, 2026 — 48,616 shares at $13.25 per share.
Total proceeds: $644,162.
Shares owned after transaction: As part of the merger, outstanding common shares (and restricted awards) were converted into cash. The filing indicates the shares were converted into cash consideration at the effective time of the merger (so the insider no longer holds those public common shares).
Notable footnotes: The disposition occurred pursuant to the Merger Agreement dated May 6, 2026 — at the merger effective time, each outstanding share was converted into the right to receive $13.25 cash; restricted stock awards vested, were cancelled, and converted to cash at the same price.
Filing timeliness: No late filing is indicated in the provided report.

Context

This was not an open-market sale but a merger-related cash conversion of shares into the agreed merger consideration. Such transactions reflect corporate action (merger consideration) rather than an insider-initiated buy or sell decision.

Form 4Exit

Period: 2026-07-21

Director

Transactions

Disposition to Issuer
Common Stock
[F1][F2]
2026-07-21$13.25/sh−48,616$644,162→ 0 total

Footnotes (2)

[F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
[F2]at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.

Signature

/s/ Janice Elizabeth Nevin|2026-07-21

1 file